303 related articles for article (PubMed ID: 33980691)
1. Genetic Evidence for Different Adiposity Phenotypes and Their Opposing Influences on Ectopic Fat and Risk of Cardiometabolic Disease.
Martin S; Cule M; Basty N; Tyrrell J; Beaumont RN; Wood AR; Frayling TM; Sorokin E; Whitcher B; Liu Y; Bell JD; Thomas EL; Yaghootkar H
Diabetes; 2021 Aug; 70(8):1843-1856. PubMed ID: 33980691
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension.
Ji Y; Yiorkas AM; Frau F; Mook-Kanamori D; Staiger H; Thomas EL; Atabaki-Pasdar N; Campbell A; Tyrrell J; Jones SE; Beaumont RN; Wood AR; Tuke MA; Ruth KS; Mahajan A; Murray A; Freathy RM; Weedon MN; Hattersley AT; Hayward C; Machann J; Häring HU; Franks P; de Mutsert R; Pearson E; Stefan N; Frayling TM; Allebrandt KV; Bell JD; Blakemore AI; Yaghootkar H
Diabetes; 2019 Jan; 68(1):207-219. PubMed ID: 30352878
[TBL] [Abstract][Full Text] [Related]
3. Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation.
Martin S; Tyrrell J; Thomas EL; Bown MJ; Wood AR; Beaumont RN; Tsoi LC; Stuart PE; Elder JT; Law P; Houlston R; Kabrhel C; Papadimitriou N; Gunter MJ; Bull CJ; Bell JA; Vincent EE; Sattar N; Dunlop MG; Tomlinson IPM; Lindström S; ; Bell JD; Frayling TM; Yaghootkar H
Elife; 2022 Jan; 11():. PubMed ID: 35074047
[TBL] [Abstract][Full Text] [Related]
4. Disentangling the impact of gluteofemoral versus visceral fat accumulation on cardiometabolic health using sex-stratified Mendelian randomization.
Gagnon E; Paulin A; Mitchell PL; Arsenault BJ
Atherosclerosis; 2023 Dec; 386():117371. PubMed ID: 38029505
[TBL] [Abstract][Full Text] [Related]
5. Beyond apples and pears: sex-specific genetics of body fat percentage.
Roshandel D; Lu T; Paterson AD; Dash S
Front Endocrinol (Lausanne); 2023; 14():1274791. PubMed ID: 37867527
[TBL] [Abstract][Full Text] [Related]
6. Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease.
Yaghootkar H; Lotta LA; Tyrrell J; Smit RA; Jones SE; Donnelly L; Beaumont R; Campbell A; Tuke MA; Hayward C; Ruth KS; Padmanabhan S; Jukema JW; Palmer CC; Hattersley A; Freathy RM; Langenberg C; Wareham NJ; Wood AR; Murray A; Weedon MN; Sattar N; Pearson E; Scott RA; Frayling TM
Diabetes; 2016 Aug; 65(8):2448-60. PubMed ID: 27207519
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis.
Parisinos CA; Wilman HR; Thomas EL; Kelly M; Nicholls RC; McGonigle J; Neubauer S; Hingorani AD; Patel RS; Hemingway H; Bell JD; Banerjee R; Yaghootkar H
J Hepatol; 2020 Aug; 73(2):241-251. PubMed ID: 32247823
[TBL] [Abstract][Full Text] [Related]
8. The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat.
Lind L; Salihovic S; Risérus U; Kullberg J; Johansson L; Ahlström H; Eriksson JW; Oscarsson J
J Clin Endocrinol Metab; 2021 Jan; 106(1):e118-e129. PubMed ID: 33123723
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
[TBL] [Abstract][Full Text] [Related]
11. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease.
Karlsson T; Rask-Andersen M; Pan G; Höglund J; Wadelius C; Ek WE; Johansson Å
Nat Med; 2019 Sep; 25(9):1390-1395. PubMed ID: 31501611
[TBL] [Abstract][Full Text] [Related]
12. A pilot investigation of visceral fat adiposity and gene expression profile in peripheral blood cells.
Yamaoka M; Maeda N; Nakamura S; Kashine S; Nakagawa Y; Hiuge-Shimizu A; Okita K; Imagawa A; Matsuzawa Y; Matsubara K; Funahashi T; Shimomura I
PLoS One; 2012; 7(10):e47377. PubMed ID: 23091619
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
[TBL] [Abstract][Full Text] [Related]
14. Ectopic fat and cardiometabolic and vascular risk.
Lim S; Meigs JB
Int J Cardiol; 2013 Nov; 169(3):166-76. PubMed ID: 24063931
[TBL] [Abstract][Full Text] [Related]
15. Beyond central adiposity: liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients.
Faria G; Gonçalves A; Cunha R; Guimarães JT; Calhau C; Preto J; Taveira-Gomes A
Int J Surg; 2015 Feb; 14():75-9. PubMed ID: 25599918
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of human visceral obesity: an update.
Tchernof A; Després JP
Physiol Rev; 2013 Jan; 93(1):359-404. PubMed ID: 23303913
[TBL] [Abstract][Full Text] [Related]
17. Cross-Sectional Associations of Computed Tomography (CT)-Derived Adipose Tissue Density and Adipokines: The Framingham Heart Study.
Lee JJ; Pedley A; Hoffmann U; Massaro JM; Keaney JF; Vasan RS; Fox CS
J Am Heart Assoc; 2016 Feb; 5(3):e002545. PubMed ID: 26927600
[TBL] [Abstract][Full Text] [Related]
18. Genetic Evidence for Distinct Biological Mechanisms That Link Adiposity to Type 2 Diabetes: Toward Precision Medicine.
Abraham A; Cule M; Thanaj M; Basty N; Hashemloo MA; Sorokin EP; Whitcher B; Burgess S; Bell JD; Sattar N; Thomas EL; Yaghootkar H
Diabetes; 2024 Jun; 73(6):1012-1025. PubMed ID: 38530928
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035
[TBL] [Abstract][Full Text] [Related]
20. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
